Philippe Kerr

Postdoc @CopenhagenPsych |

Allostatic load | Depression | Treatment response | Network analysis | Comorbidity

[Philippe Kerr @KerrPhilippe]

Don't miss out on this one! Still a few days to register 👀

[ISPNE @ISPNE]

The webinar is in four days! Register today at https://t.co/lQW8HWClzH

[Philippe Kerr @KerrPhilippe]

@ISPNE is proud to present the first webinar of our 2024-2025 series on individual differences in psychoneuroendocrine research! First up will be on Nov 11th, where @Rob_Paul_Juster will be presenting on sex and gender differences in stress and health. Do not miss it! 👀

[ISPNE @ISPNE]

Announcing our November Webinar! Register today at https://t.co/lQW8HWClzH

[Philippe Kerr @KerrPhilippe]

@EikoFried Reporting p-values alone with no effect sizes is probably the one I have encountered most. Also, I think there is a distinction to be made between statistical and clinical significance that is not discussed very often.

[Philippe Kerr @KerrPhilippe]

@MiriForbes @stopharmingus Really good paper that discusses this idea and cites meta-analyses on the topic:

Fried, E.I., Nesse, R.M. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med 13, 72 (2015). https://t.co/8ys3NZJZZR

[Philippe Kerr @KerrPhilippe]

@DrSKPsych Thanks for the feedback! :)

[Philippe Kerr @KerrPhilippe]

Systematic review folks.

When reporting reasons for excluding a paper from your systematic review, do you typically report the first exclusion criteria that was identified during eligibility screening or list each exclusion criteria that was met for the excluded paper?

[Philippe Kerr @KerrPhilippe]

@EikoFried A vested interest in designing an ESM/EMA study using smartphones would be my guess.

[Philippe Kerr @KerrPhilippe]

@JAMAPsych @LElkrief

[Philippe Kerr @KerrPhilippe]

@CorriveauNick Félicitations mon ami! Longue vie à vous deux 😌🎉🥂

[PsychiatryAmsterdam @PsychRes]

Not sure which #biomarkers to select for your mental health studies? Our latest review provides guidelines on incorporating biological assessments into clinical studies. We address biomarkers, pathways, and measurement variability. See our insights here: https://t.co/tHuKwIDS8l

[Philippe Kerr @KerrPhilippe]

@ProfArmour @QUBPsych @uni_copenhagen @CopenhagenPsych @MartinFRobinson @kikarstoft It was so nice meeting all of you and hearing about the fascinating research you are doing! Looking forward to next time 😌

[Eiko Fried @EikoFried]

“Don’t worry about measurement, we will fix that in the analysis stage”

[Philippe Kerr @KerrPhilippe]

Mina Guérin and Fanny Saulnier, two brilliant graduate students from @laboCESAR are working on a sex and gender based systematic review on the effects of gender stereotypes on cognitive performance. Any unpublished reports or gray literature to share would be helpful. Thanks :)

[Philippe Kerr @KerrPhilippe]

Way to kick off #NordicEpi2024 with a fascinating talk on complexity science in public health by @HulvejRod

[Philippe Kerr @KerrPhilippe]

@EikoFried Recruiting 74k participants between 2009 and 2022, with more than 70% from the same hospital. Suuuuure. 😂 Tough scene.

[Philippe Kerr @KerrPhilippe]

@introspection Félicitations, c'est très bien mérité! 🎉

[Philippe Kerr @KerrPhilippe]

@EikoFried This is unfortunate. From my perspective (trained in HPA-axis/dep), I believe our ability to map clinically meaningful endophenotypes is contingent on strong psychological theories, which are indeed, rarely discussed. Perhaps a missed opportunity waiting to be grasped. 👀

[Philippe Kerr @KerrPhilippe]

@EikoFried Very catchy and easy to remember 😂

[Philippe Kerr @KerrPhilippe]

@giollabhui @dp_moriarity @MondelliValeria @YMilaneschi @ABorsini @GeorgeSlavich et al. have published some amazing reviews on the topic of inflammation and depression, and I am pretty sure they have addressed the topic of sex differences. Maybe they also covered this in a symptom-specific way? :)